Search

everythinglearnresearchcommunity

for

Search:↓

MK-0773 safely increased muscle mass but did not improve muscle strength or function in elderly women with sarcopenia.

SARMs may be an effective treatment for a certain type of breast cancer by blocking cancer growth and spread.

GTx-024 and Danazol affect the uterus like DHT, while GTx-007 has little impact.

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.

Enobosarm may effectively treat androgen receptor-positive breast cancer with fewer side effects.

SARMs work differently in tissues due to unique interactions and structures.

Anabolic steroids can build muscle and strength but have risks and need more research on their clinical benefits and side effects.

Enobosarm significantly increased muscle mass and improved physical function in elderly men and postmenopausal women without serious side effects.

Researchers developed new compounds that target the androgen receptor effectively with fewer side effects.

New treatments for male hypogonadism are effective and should be personalized.

Selective androgen receptor modulators (SARMs) are a promising type of drug for various health conditions due to their targeted actions.

Two new compounds were found to build bone and muscle without affecting reproductive organs and skin oil glands.

Muscles can make their own androgens, which may help muscle growth.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

New androgen receptor modulators show promise for treating diseases like prostate cancer and muscle wasting.

New treatments for low male hormones improved sexual function and mood but had unclear risks, especially for older men.

Scientists have developed a new method to detect steroid abuse in athletes using cell-based tests, which could be the future of anti-doping methods.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Certain changes to the B-ring of androgen receptor ligands can increase their effectiveness for potential treatments of muscle and bone conditions.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Androgens and SARMs play a role in body mass, frailty, skin health, and hair growth, and are used in treating prostate cancer, acne, and hair loss, with potential for new uses and improved versions in the future.

Nandrolone and oxandrolone could help treat male health issues like muscle loss and low testosterone.

We need better ways to test and understand SARMs to make safer and more effective treatments.

New treatments for male hypogonadism are easier to use and target specific tissues to reduce side effects.

Genetic defects in testosterone production can cause hormonal and developmental disorders, and more research is needed to understand androgen regulation and develop safer treatments.

SARMs show promise but need more evidence to prove they're better than traditional androgens.

Anabolic steroids boost muscle growth, SARMs increase muscle mass and bone density without side effects, and myostatin inhibitors block a protein that stops muscle growth, but each has potential risks.

Different substances that activate or block the androgen receptor can affect male development and treat conditions like prostate cancer.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.